Aralez Pharmaceuticals Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$23.1M

145 transactions

Summary

Aralez Pharmaceuticals Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $4.2MSales: $17.4M17 insiders

Date	Insider	Type	Value
2017-05-22	Aryeh Jason	Sell	$332K
2017-06-05	KOVEN ANDREW I(President & Chief Business Off)	Sell	$207K
2017-05-23	Aryeh Jason	Sell	$147K
2017-05-19	Aryeh Jason	Sell	$80K
2017-12-08	Kirsch Arthur S	Buy	$74K
2017-06-14	Kirsch Arthur S	Buy	$59K
2018-06-04	KOVEN ANDREW I(President & Chief Business Off)	Sell	$58K
2017-10-02	Tursi James Patrick(Chief Medical Officer)	Sell	$25K
2017-06-15	Kirsch Arthur S	Buy	$17K
2018-03-19	KOVEN ANDREW I(President & Chief Business Off)	Sell	$17K
2017-07-28	Charles Scott J(Chief Financial Officer)	Sell	$14K
2017-06-23	Trachtenberg Eric(GC, CCO & Secretary)	Sell	$10K
2018-03-19	Tursi James Patrick(Chief Medical Officer)	Sell	$10K
2018-03-19	Glickman Mark A(Chief Commercial Officer)	Sell	$10K
2018-05-14	KOVEN ANDREW I(President & Chief Business Off)	Sell	$7K
2018-03-19	Trachtenberg Eric(GC, CCO & Secretary)	Sell	$6K
2018-05-14	Tursi James Patrick(Chief Medical Officer)	Sell	$5K
2018-03-15	Kaseta Michael(Chief Financial Officer)	A	$0
2018-03-15	Kaseta Michael(Chief Financial Officer)	A	$0
2017-11-30	Kaseta Michael(Interim CFO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Aralez Pharmaceuticals Inc. — Contributions, Lobbying & Contracts | Poliscope